The epidermal growth factor receptor (EGFR) plays an important role in colorectal cancer by activating key signaling pathways, such as Ras-MAPK and PI3K-Akt, which drive tumor growth, angiogenesis, and survival [15]. This evidence concerns the gene AKT1 and colorectal cancer.